McKesson reported FY2026 revenue of $403.4 billion and FY2026 operating income of $6.2 billion. The thesis depends on pharma distribution scale, specialty growth, working capital, margins and cash conversion.
References
Sources used in this report
SEC datasetSEC company tickers exchange datasetRetrieved 2026-05-20 · Issuer identity, exchange, ticker and CIK.SEC APISEC submissions APIRetrieved 2026-05-20 · Filing chronology and accession records.SEC XBRL APISEC companyfacts APIRetrieved 2026-05-20 · Financial statement cross-checks.Annual reportAnnual report2026-05-08 · Business, risk and annual financial disclosure.Quarterly reportLatest Form 10-Q2026-02-04 · Latest interim financials.Current reportLatest Form 8-K2026-05-07 · Latest current-report context.Proxy statementProxy statement2025-06-20 · Governance and incentives.